Gentamicin for Junctional Epidermolysis Bullosa — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Gentamicin for Junctional Epidermolysis Bullosa — Stella

Home/Junctional Epidermolysis Bullosa/

View on ClinicalTrials.gov

Recruiting

Back to Junctional Epidermolysis Bullosa trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

University of Southern California, Los Angeles, California

Key details

Phase

Early testing / Safety & dosing

Sponsor

University of Southern California

Enrollment target

~6 participants

Started

June 2018

Primary completion

July 2020

This trial's estimated completion date has passed — the record may not be fully up to date.

Last updated April 2020

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.